Overview
Pangea Biomed is an Israeli oncology drug developer
Funding
Amounts as reported; USD estimates shown only when they matchListed 2 funding records. Latest funding: $5M (Angel), Dec 15, 2022.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Dec 15, 2022 | $5M · Angel | Danny Tocatly, NFX | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
| Apr 7, 2022 | $7M · Seed | NFX | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 2 valuation records.
No chartable valuation estimates yet.
2 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Dec 15, 2022 | — · Angel | Danny Tocatly, NFX | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
| Apr 7, 2022 | — · Seed | NFX | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
以色列肿瘤药物开发商 Pangea Biomed是一家以色列肿瘤药物开发商